Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!).

Osteoarthritis (OA) has long been considered a "wear and tear" disease leading to loss of cartilage. OA used to be considered the sole consequence of any process leading to increased pressure on one particular joint or fragility of cartilage matrix. Progress in molecular biology in the 1990s has profoundly modified this paradigm. The discovery that many soluble mediators such as cytokines or prostaglandins can increase the production of matrix metalloproteinases by chondrocytes led to the first steps of an "inflammatory" theory. However, it took a decade before synovitis was accepted as a critical feature of OA, and some studies are now opening the way to consider the condition a driver of the OA process. Recent experimental data have shown that subchondral bone may have a substantial role in the OA process, as a mechanical damper, as well as a source of inflammatory mediators implicated in the OA pain process and in the degradation of the deep layer of cartilage. Thus, initially considered cartilage driven, OA is a much more complex disease with inflammatory mediators released by cartilage, bone and synovium. Low-grade inflammation induced by the metabolic syndrome, innate immunity and inflammaging are some of the more recent arguments in favor of the inflammatory theory of OA and highlighted in this review.

[1]  S. Middeldorp,et al.  Association between weight or body mass index and hand osteoarthritis: a systematic review , 2009, Annals of the rheumatic diseases.

[2]  P. Richette,et al.  Oestrogens inhibit interleukin 1beta-mediated nitric oxide synthase expression in articular chondrocytes through nuclear factor-kappa B impairment. , 2007, Annals of the rheumatic diseases.

[3]  Clinical features of osteoarthritis , 2015 .

[4]  T. Huizinga,et al.  Mast cells are the main interleukin 17-positive cells in anticitrullinated protein antibody-positive and -negative rheumatoid arthritis and osteoarthritis synovium , 2011, Arthritis research & therapy.

[5]  F. Berenbaum,et al.  Clinical Features of Osteoarthritis , 2009 .

[6]  J. Campisi,et al.  The senescence-associated secretory phenotype: the dark side of tumor suppression. , 2010, Annual review of pathology.

[7]  U. Müller-Ladner,et al.  Increased serum adiponectin levels in female patients with erosive compared with non-erosive osteoarthritis , 2009, Annals of the rheumatic diseases.

[8]  K. Nishioka,et al.  Presence of pannus-like tissue on osteoarthritic cartilage and its histological character. , 2003, Osteoarthritis and cartilage.

[9]  J. Bijlsma,et al.  Serum adipokines in osteoarthritis; comparison with controls and relationship with local parameters of synovial inflammation and cartilage damage. , 2012, Osteoarthritis and cartilage.

[10]  Jonathan Samuels,et al.  Increased interleukin-1β gene expression in peripheral blood leukocytes is associated with increased pain and predicts risk for progression of symptomatic knee osteoarthritis. , 2011, Arthritis and rheumatism.

[11]  F. Berenbaum,et al.  Induction of the chemokine IL-8/Kc by the articular cartilage: possible influence on osteoarthritis. , 2012, Joint, bone, spine : revue du rhumatisme.

[12]  J. Pelletier,et al.  High mobility group box 1 potentiates the pro-inflammatory effects of interleukin-1β in osteoarthritic synoviocytes , 2010, Arthritis research & therapy.

[13]  S Gary Firestein,et al.  Kelley's Textbook of Rheumatology , 2004 .

[14]  W. Maksymowych,et al.  Targeting tumour necrosis factor alleviates signs and symptoms of inflammatory osteoarthritis of the knee , 2012, Arthritis Research & Therapy.

[15]  W. B. van den Berg,et al.  Synovial lining macrophages mediate osteophyte formation during experimental osteoarthritis. , 2004, Osteoarthritis and cartilage.

[16]  M. Lotz,et al.  Effects of aging on articular cartilage homeostasis. , 2012, Bone.

[17]  R. Loeser,et al.  AGING AND OSTEOARTHRITIS , 1957, Current opinion in rheumatology.

[18]  F. Berenbaum Signaling transduction: target in osteoarthritis , 2004, Current opinion in rheumatology.

[19]  M. O’Banion,et al.  Osteoarthritis accelerates and exacerbates Alzheimer's disease pathology in mice , 2011, Journal of Neuroinflammation.

[20]  N. Oreiro,et al.  Identification of a panel of novel serum osteoarthritis biomarkers. , 2011, Journal of proteome research.

[21]  D. Walsh,et al.  Inflammation and angiogenesis in osteoarthritis. , 2003, Arthritis and rheumatism.

[22]  S. Goldring,et al.  Osteoarthritis: a disease of the joint as an organ. , 2012, Arthritis and rheumatism.

[23]  R. Puenpatom,et al.  Increased Prevalence of Metabolic Syndrome in Individuals with Osteoarthritis: An Analysis of NHANES III Data , 2009, Postgraduate medicine.

[24]  P. Slagboom,et al.  Association between leptin, adiponectin and resistin and long-term progression of hand osteoarthritis , 2011, Annals of the rheumatic diseases.

[25]  F. Berenbaum,et al.  Adipokines in Arthritis: New Kids on the Block , 2009 .

[26]  P. Scherer,et al.  Adipokines as novel biomarkers and regulators of the metabolic syndrome , 2010, Annals of the New York Academy of Sciences.

[27]  M. Karsdal,et al.  An update review of cellular mechanisms conferring the indirect and direct effects of estrogen on articular cartilage , 2008, Climacteric : the journal of the International Menopause Society.

[28]  M. Crow,et al.  Innate immune system activation in osteoarthritis: is osteoarthritis a chronic wound? , 2008, Current opinion in rheumatology.

[29]  P. Richette,et al.  Oestrogens inhibit interleukin 1β-mediated nitric oxide synthase expression in articular chondrocytes through nuclear factor-κB impairment , 2006 .

[30]  H. Potter,et al.  Local cytokine profiles in knee osteoarthritis: elevated synovial fluid interleukin-15 differentiates early from end-stage disease. , 2009, Osteoarthritis and cartilage.

[31]  F. Berenbaum,et al.  Obesity and osteoarthritis: more complex than predicted! , 2006, Annals of the rheumatic diseases.

[32]  M. Cho,et al.  The catabolic pathway mediated by Toll-like receptors in human osteoarthritic chondrocytes. , 2006, Arthritis and rheumatism.

[33]  J. Gómez-Reino,et al.  What's new in our understanding of the role of adipokines in rheumatic diseases? , 2011, Nature Reviews Rheumatology.

[34]  A. Cole,et al.  Increased matrix metalloproteinase-13 production with aging by human articular chondrocytes in response to catabolic stimuli. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[35]  M. Dougados,et al.  Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis -- results of a 1 year longitudinal arthroscopic study in 422 patients. , 2005, Osteoarthritis and cartilage.

[36]  M. Hussein,et al.  Alterations of the CD4+, CD8+ T Cell Subsets, Interleukins-1β, IL-10, IL-17, Tumor Necrosis Factor-α and Soluble Intercellular Adhesion Molecule-1 in Rheumatoid Arthritis and Osteoarthritis: Preliminary Observations , 2008, Pathology & Oncology Research.

[37]  Kim M. Huffman,et al.  Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation , 2011, Proceedings of the National Academy of Sciences.

[38]  Kozo Nakamura,et al.  Accumulation of metabolic risk factors such as overweight, hypertension, dyslipidaemia, and impaired glucose tolerance raises the risk of occurrence and progression of knee osteoarthritis: a 3-year follow-up of the ROAD study. , 2012, Osteoarthritis and cartilage.

[39]  J. Verhaar,et al.  The infrapatellar fat pad should be considered as an active osteoarthritic joint tissue: a narrative review. , 2010, Osteoarthritis and cartilage.

[40]  F. Berenbaum,et al.  Stress-induced cartilage degradation does not depend on the NLRP3 inflammasome in human osteoarthritis and mouse models. , 2012, Arthritis and rheumatism.

[41]  E. Huskisson,et al.  Crystals, inflammation and osteoarthritis. , 1977, Acta rhumatologica Belgica.

[42]  T. Griffin,et al.  Pathobiology of obesity and osteoarthritis: integrating biomechanics and inflammation , 2012, Pathobiology of aging & age related diseases.

[43]  W. Lems,et al.  Active involvement of alarmins S100A8 and S100A9 in the regulation of synovial activation and joint destruction during mouse and human osteoarthritis. , 2012, Arthritis and rheumatism.

[44]  H. Brenner,et al.  Severity and extent of osteoarthritis and low grade systemic inflammation as assessed by high sensitivity C reactive protein , 2004, Annals of the rheumatic diseases.

[45]  F. Martinon,et al.  Gout-associated uric acid crystals activate the NALP3 inflammasome , 2006, Nature.

[46]  N. Akhtar,et al.  Advanced glycation end products induce the expression of interleukin-6 and interleukin-8 by receptor for advanced glycation end product-mediated activation of mitogen-activated protein kinases and nuclear factor-κB in human osteoarthritis chondrocytes. , 2011, Rheumatology.

[47]  O. Leo,et al.  Pharmacological Inhibition of Nicotinamide Phosphoribosyltransferase/Visfatin Enzymatic Activity Identifies a New Inflammatory Pathway Linked to NAD , 2008, PloS one.

[48]  Z. Bi,et al.  Dendritic Cells of Synovium in Experimental Model of Osteoarthritis of Rabbits , 2012, Cellular Physiology and Biochemistry.

[49]  Johanne Martel-Pelletier,et al.  Role of proinflammatory cytokines in the pathophysiology of osteoarthritis , 2011, Nature Reviews Rheumatology.

[50]  E. Distel,et al.  The infrapatellar fat pad in knee osteoarthritis: an important source of interleukin-6 and its soluble receptor. , 2009, Arthritis and rheumatism.

[51]  A. Guermazi,et al.  Imaging of osteoarthritis: update from a radiological perspective , 2011, Current opinion in rheumatology.

[52]  Claudio Franceschi,et al.  Innate immunity and inflammation in ageing: a key for understanding age-related diseases , 2005, Immunity & Ageing.

[53]  F. Berenbaum,et al.  Osteoarthritis: an update with relevance for clinical practice , 2011, The Lancet.

[54]  K. Clément,et al.  Benefits of massive weight loss on symptoms, systemic inflammation and cartilage turnover in obese patients with knee osteoarthritis , 2010, Annals of the rheumatic diseases.

[55]  T. Wyss-Coray,et al.  Identification of a central role for complement in osteoarthritis , 2011, Nature Medicine.

[56]  W. Robinson,et al.  Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via Toll-like receptor 4 , 2012, Arthritis Research & Therapy.

[57]  F. Berenbaum,et al.  Prostaglandin E2 synthesis in cartilage explants under compression: mPGES-1 is a mechanosensitive gene , 2006, Arthritis research & therapy.

[58]  S. Libregts,et al.  Crucial role of macrophages in matrix metalloproteinase-mediated cartilage destruction during experimental osteoarthritis: involvement of matrix metalloproteinase 3. , 2007, Arthritis and rheumatism.

[59]  J. Pfeilschifter,et al.  Changes in proinflammatory cytokine activity after menopause. , 2002, Endocrine reviews.

[60]  S. Akira,et al.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors , 2010, Nature Immunology.

[61]  A. Statnikov,et al.  Inflammatory genomic and plasma biomarkers predict progression of symptomatic knee OA (SKOA) , 2012 .

[62]  T. Glant,et al.  Synovial fluid from patients with early osteoarthritis modulates fibroblast-like synoviocyte responses to toll-like receptor 4 and toll-like receptor 2 ligands via soluble CD14. , 2012, Arthritis and rheumatism.

[63]  Farshid Guilak,et al.  Biomechanical factors in osteoarthritis. , 2011, Best practice & research. Clinical rheumatology.

[64]  Forest M White,et al.  Mechanical Injury and Cytokines Cause Loss of Cartilage Integrity and Upregulate Proteins Associated with Catabolism, Immunity, Inflammation, and Repair* , 2009, Molecular & Cellular Proteomics.

[65]  A. Cole,et al.  Articular chondrocytes express the receptor for advanced glycation end products: Potential role in osteoarthritis. , 2005, Arthritis and rheumatism.

[66]  S. Abramson,et al.  Inflammation in osteoarthritis. , 2004, The Journal of rheumatology. Supplement.

[67]  A. Tedgui,et al.  Cytokines in atherosclerosis: pathogenic and regulatory pathways. , 2006, Physiological reviews.

[68]  D. Loeuille,et al.  Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study. , 2009, Arthritis and rheumatism.

[69]  T. Sculco,et al.  Elevated high-sensitivity C-reactive protein levels are associated with local inflammatory findings in patients with osteoarthritis. , 2007, Osteoarthritis and cartilage.

[70]  F. Berenbaum,et al.  Crucial role of visfatin/pre-B cell colony-enhancing factor in matrix degradation and prostaglandin E2 synthesis in chondrocytes: possible influence on osteoarthritis. , 2008, Arthritis and rheumatism.

[71]  Y. Henrotin,et al.  Regulation of subchondral bone osteoblast metabolism by cyclic compression. , 2012, Arthritis and rheumatism.

[72]  Francis Berenbaum,et al.  The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis , 2010, Nature Reviews Rheumatology.

[73]  J. Katz,et al.  Synovial inflammation in patients undergoing arthroscopic meniscectomy: molecular characterization and relationship to symptoms. , 2011, Arthritis and rheumatism.

[74]  Pankaj Kapahi,et al.  Cellular senescence: a link between cancer and age-related degenerative disease? , 2011, Seminars in cancer biology.

[75]  Siamon Gordon,et al.  Pattern Recognition Receptors Doubling Up for the Innate Immune Response , 2002, Cell.

[76]  D. Walsh,et al.  Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis , 2012, Nature Reviews Rheumatology.

[77]  G. Mccarthy,et al.  Detection of basic calcium phosphate crystals in osteoarthritis. , 2011, Joint, bone, spine : revue du rhumatisme.

[78]  O. Franco,et al.  Association of atherosclerosis with presence and progression of osteoarthritis: the Rotterdam Study , 2012, Annals of the rheumatic diseases.

[79]  J. Ashton-Miller,et al.  Knee osteoarthritis in obese women with cardiometabolic clustering. , 2009, Arthritis and rheumatism.

[80]  Ali Guermazi,et al.  Presence of MRI-detected joint effusion and synovitis increases the risk of cartilage loss in knees without osteoarthritis at 30-month follow-up: the MOST study , 2011, Annals of the rheumatic diseases.